Strategic Global Advisors’s Celgene Corp CELG Stock Holding History

Strategic Global Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,198	Closed	-$333K	–	203
2018 Q4	$333K	Sell	5,198 -775	-13%	-$57.2K	0.12%	129
2018 Q3	$535K	Sell	5,973 -24	-0.4%	-$2.12K	0.16%	113
2018 Q2	$535K	Hold	5,997	–	–	0.14%	112
2018 Q1	$535K	Hold	5,997	–	–	0.18%	102
2017 Q4	$626K	Sell	5,997 -250	-4%	-$28.2K	0.2%	96
2017 Q3	$911K	Hold	6,247	–	–	0.35%	77
2017 Q2	$811K	Buy	6,247 +3,490	+127%	+$428K	0.3%	81
2017 Q1	$343K	Buy	+2,757	New	+$330K	0.12%	132
2015 Q1	–	Sell	-7,713	Closed	-$862K	–	146
2014 Q4	$862K	Buy	+7,713	New	+$813K	0.77%	42

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Strategic Global Advisors's CELG Position: Q1 2019 in Review

Strategic Global Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 5,198 shares — an estimated $333K sold.

Strategic Global Advisors first reported a position in CELG in Q4 2014 and held it in 9 quarters. The position peaked at $911K in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Strategic Global Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Strategic Global Advisors sold 5,198 Celgene Corp shares in Q1 2019, an estimated $333K.
Strategic Global Advisors first reported a position in Celgene Corp in Q4 2014 and held it in 9 quarters.
Strategic Global Advisors's Celgene Corp position peaked at $911K in Q3 2017.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Strategic Global Advisors's 13F filing for Q1 2019, filed 13 May 2019.